View in EDS

The MELimmune score-prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy-a multicentre, retrospective cohort study.

Saved in:
Bibliographic Details
Title: The MELimmune score-prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy-a multicentre, retrospective cohort study.
Authors: Lobo-Martins S; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto Medicina Molecular João Lobo Antunes, LCosta Lab-Lisbon School of Medicine, Lisbon, Portugal., Martins-Branco D; Instituto Português de Oncologia Lisboa Francisco Gentil, Lisbon, Portugal., Semedo PM; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal., Alvim CM; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto Medicina Molecular João Lobo Antunes, LCosta Lab-Lisbon School of Medicine, Lisbon, Portugal., Monteiro AM; Instituto Português de Oncologia Lisboa Francisco Gentil, Lisbon, Portugal., Vendrell I; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal., Gouveia E; Instituto Português de Oncologia Lisboa Francisco Gentil, Lisbon, Portugal., Passos MJ; Instituto Português de Oncologia Lisboa Francisco Gentil, Lisbon, Portugal., Costa L; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto Medicina Molecular João Lobo Antunes, LCosta Lab-Lisbon School of Medicine, Lisbon, Portugal.; Lisbon School of Medicine, Lisbon, Portugal., Mansinho A; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto Medicina Molecular João Lobo Antunes, LCosta Lab-Lisbon School of Medicine, Lisbon, Portugal., de Sousa RT; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto Medicina Molecular João Lobo Antunes, LCosta Lab-Lisbon School of Medicine, Lisbon, Portugal.
Source: Immuno-oncology technology [Immunooncol Technol] 2025 Feb 03; Vol. 25, pp. 101043. Date of Electronic Publication: 2025 Feb 03 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918281581106676 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0188 (Electronic) Linking ISSN: 25900188 NLM ISO Abbreviation: Immunooncol Technol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2590-0188
DOI:10.1016/j.iotech.2025.101043